Table 1. miRNAs significantly deregulated between 13q- CLL subgroups (patients with 80% or more of cells with 13q deletion and patients with less than 80% 13q cells).

miRNA	Map	q-value	R fold
Down-regulated
hsa-mir-1-1*	20q13.33	0.0125	0.7027
hsa-mir-7-1	9q21.32	0.0397	0.5453
hsa-mir-15a	13q14.3	0.0329	0.4917
hsa-mir-29a	7q32.3	0.0354	0.5101
hsa-mir-34a*	1p36.23	0.0366	0.6874
hsa-mir-106b*	7q22.1	0.0280	0.5190
hsa-mir-181b	1q31.3	0.0256	0.6775
hsa-mir-204	9q21.11	0.0294	0.5693
hsa-mir-206	6p12.2	0.0476	0.7077
hsa-mir-221*	Xp11.3	0.0133	0.4622
hsa-mir-223*	Xq12	0.0017	0.1016
Up-regulated
hsa-mir-134	14q32.31	0.0095	1.8096
hsa-mir-105-2	Xq28	0.0182	1.4040
hsa-mir-155*	21q21.3	0.0046	3.7013
hsa-mir-205	1q32.2	0.0161	1.3830

Upregulation or downregulation refers to 13q-H relative to13q-L CLL patients.

miRNA: microRNA.

^*deregulation shared with 17p/11q CLL patients.